Singulair
Singulair Price range: $ 42,00 through $ 502,00
Back to products
Slim Trim Active
Slim Trim Active Price range: $ 54,00 through $ 145,00

Skelaxin

Price range: $ 74,00 through $ 417,00

Skelaxin is an effective muscle relaxant specifically designed to alleviate the discomfort associated with acute, painful musculoskeletal conditions. This medication works by targeting the body’s central nervous system to help reduce muscle spasms and localized pain. It is primarily used to treat stiffness and tension resulting from strains, sprains, and other various muscle injuries. When combined with rest and physical therapy, Skelaxin helps significantly improve the recovery process for many patients. By easing physical distress, this treatment allows individuals to regain mobility and return to their normal daily activities with greater ease.

Active substance: Metaxalone
SKU: Skelaxin Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Skelaxin belongs to a group of medicines known as central nervous system skeletal muscle relaxants. It is prescribed as an adjunct to rest, physical therapy, and other supportive care measures to relieve discomfort associated with acute, painful musculoskeletal conditions.

In the United States, Skelaxin is available exclusively by prescription (Rx) and must be dispensed in accordance with applicable federal and state regulations under the supervision of a licensed healthcare provider. The active pharmaceutical ingredient in Skelaxin is metaxalone.

Parameter Details
Active ingredient Metaxalone
Therapeutic class Skeletal muscle relaxant (CNS depressant)
Dosage form Oral tablet (800 mg)
Route of administration Oral
Primary purpose Relief of discomfort associated with acute musculoskeletal conditions
Prescription status Prescription-only (Rx)

Prescription Information and Overview

What it’s used for

Skelaxin is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is intended for short-term management during the acute phase of muscle spasms or traumatic muscular injuries, such as strains, sprains, or local tissue trauma. Skelaxin does not replace physical rehabilitation, rest, or non-pharmacologic interventions, but rather functions as a supportive component of a comprehensive treatment plan. Any application outside of acute musculoskeletal pain is considered off-label and requires specific diagnostic evaluation and determination by a qualified prescriber. Skelaxin is not indicated for chronic spasticity or muscle spasms secondary to cerebral palsy or spinal cord lesions.

How the drug works

The exact mechanism of action of metaxalone, the active drug component in Skelaxin, has not been fully established in human clinical studies. Unlike neuromuscular blocking agents, metaxalone does not exert direct action on the contractile mechanism of striated muscle, the motor endplate, or nerve fibers. Instead, its clinical effectiveness is attributed to general central nervous system (CNS) depression. By dampening polysynaptic spinal cord reflexes and subcortical pathways, Skelaxin helps diminish hyperactive muscular tone and secondary painful reflex spasms. This systemic CNS-depressant action helps reduce local musculoskeletal tension without completely abolishing voluntary muscle movement.

What happens in the body

Following oral administration, Skelaxin is absorbed through the gastrointestinal tract into systemic circulation. The presence of food markedly alters the pharmacokinetic parameters of metaxalone. When administered with a high-fat meal, peak plasma concentration (Cmax) and total systemic exposure (area under the curve, or AUC) increase significantly compared to administration under fasting conditions. The mean elimination half-life of metaxalone is approximately 9 hours when taken with food, whereas under fasting conditions, the average elimination half-life is shorter, typically ranging between 2 and 3 hours. Metaxalone is extensively metabolized by the liver, involving multiple cytochrome P450 enzyme pathways (including CYP1A2, CYP2D6, CYP2E1, and CYP3A4), and its metabolites are excreted primarily by the kidneys in urine.

Dosing schedule

The recommended dosing schedule for adults and pediatric patients over 12 years of age is one 800 mg tablet taken orally three to four times daily. Dosing intervals should be distributed evenly throughout the waking hours as instructed by the prescribing physician. Because food intake substantially increases drug absorption and overall blood concentrations, patients should maintain consistency regarding whether they take their medication with meals or on an empty stomach. Skelaxin tablets should be swallowed whole with a full glass of water. Dosage adjustments or treatment duration modifications must be determined individually by a clinician based on clinical response, tolerability, and renal or hepatic function.

If you skip a dose

If a scheduled dose of Skelaxin is missed, it should be taken as soon as it is remembered, provided it is not close to the time for the next scheduled dose. If the next dose is due shortly, the missed dose should be skipped entirely, and the normal dosing schedule should be resumed. Patients should never double the dose or take extra medicine to compensate for a missed tablet, as doing so increases the risk of severe central nervous system depression and unwanted adverse effects.

Clinical Safety and Practical Considerations

What to avoid while taking it

Patients taking Skelaxin should avoid consuming alcohol or alcohol-containing beverages and over-the-counter preparations. Alcohol produces additive central nervous system depressant effects when combined with metaxalone, which can lead to severe drowsiness, dizziness, impaired motor coordination, and altered mental clarity. In addition, because high-fat meals increase metaxalone systemic exposure, patients should consult their provider or pharmacist to establish a consistent routine regarding meal timing and medication intake to avoid unexpected spikes in sedation.

Compatibility with other medicines

Skelaxin has the potential to interact with several classes of drugs due to its central nervous system depressant properties. Concurrent administration of Skelaxin with other CNS depressants–including benzodiazepines, opioid analgesics, sedatives, hypnotics, tranquilizers, or sedating antihistamines–can result in additive sedation, drowsiness, and respiratory depression. Co-administration with serotonergic agents (such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, or monoamine oxidase inhibitors) requires careful clinical evaluation due to potential risk considerations. Patients must provide their clinician and pharmacist with a complete list of all prescription medications, over-the-counter products, vitamins, and herbal supplements prior to starting therapy.

Adverse reactions

The most commonly reported adverse reactions associated with Skelaxin involve the central nervous system and the gastrointestinal system. Frequently observed side effects include drowsiness, dizziness, headache, nervousness, lightheadedness, and irritability. Gastrointestinal side effects may include nausea, vomiting, stomach upset, or epigastric distress. Less common but serious adverse events include hypersensitivity reactions (such as skin rash, pruritus, or urticaria), jaundice or abnormal liver function test results, and hematologic disturbances including hemolytic anemia or leukopenia. Patients experiencing persistent or distressing side effects should seek medical advice promptly.

Important precautions

Skelaxin is contraindicated in patients with known hypersensitivity to metaxalone or any inactive ingredients in the formulation. It is also contraindicated in individuals with a history of drug-induced, hemolytic, or other anemias, as well as in patients with significantly impaired renal or hepatic function, as decreased drug clearance can lead to drug accumulation and toxicity. Skelaxin causes central nervous system depression, which can impair mental alertness and physical abilities. Patients should be explicitly advised against operating motor vehicles, handling heavy machinery, or engaging in hazardous tasks until they are certain the medication does not impair their performance.

Special populations

The safety and effectiveness of Skelaxin in pediatric patients aged 12 years and under have not been established. In elderly individuals, dose selection should be approached cautiously, usually starting at the lower end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or drug therapies. Skelaxin should be used during pregnancy only if the potential benefit clearly justifies the potential risk to the fetus, as adequate and well-controlled studies in pregnant women are lacking. Caution should also be exercised when administering Skelaxin to nursing mothers, as it is not known whether metaxalone is excreted in human milk.

Red flags

Immediate emergency medical assistance should be sought if signs of a severe allergic reaction occur, including swelling of the face, lips, tongue, or throat, or severe difficulty breathing or swallowing. Urgent care is also required if a patient develops signs of liver dysfunction (such as yellowing of the skin or eyes, dark urine, or upper right abdominal pain), symptoms of severe blood dyscrasias (such as unusual bruising, extreme pale skin, or unexplained fever), or signs of severe drug overdose including profound somnolence, shallow breathing, or loss of consciousness.

Frequently Asked Questions

Can Skelaxin cause daytime drowsiness?

Yes, drowsiness and lightheadedness are common side effects of Skelaxin because it acts as a central nervous system depressant. Patients should evaluate how the medication affects them before driving or undertaking activities requiring complete mental alertness.

How long is a typical course of treatment with Skelaxin?

Skelaxin is intended for short-term use during the acute phase of painful musculoskeletal conditions. The duration of therapy is determined by the prescribing healthcare provider and is typically limited to several days or a few weeks in combination with rest and physical therapy.

Is it safe to drive while taking Skelaxin?

Driving is not recommended until you know how Skelaxin affects your reaction time, motor skills, and alertness. Central nervous system depression caused by metaxalone can slow reflexes and cause sedation, increasing the risk of accidents.

What should be done if an accidental overdose occurs?

In the event of an overdose, contact a poison control center (such as 1-800-222-1222 in the US) or seek emergency medical services immediately. Overdose symptoms may manifest as marked central nervous system depression, severe sedation, and respiratory compromise.

Does taking Skelaxin with food alter its effects?

Yes, taking Skelaxin with a high-fat meal significantly increases both the rate and total amount of medication absorbed into the bloodstream. To maintain consistent therapeutic levels, patients should follow their physician’s instructions regarding taking the medication consistently with respect to meal times.

In accordance with US Food and Drug Administration (FDA) guidelines. Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

400mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

Ενεργός Ουσία